JP2017515455A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017515455A5 JP2017515455A5 JP2016549476A JP2016549476A JP2017515455A5 JP 2017515455 A5 JP2017515455 A5 JP 2017515455A5 JP 2016549476 A JP2016549476 A JP 2016549476A JP 2016549476 A JP2016549476 A JP 2016549476A JP 2017515455 A5 JP2017515455 A5 JP 2017515455A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- fucosyltransferase
- lactose
- bacteroides
- utilizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 101000893710 Homo sapiens Galactoside alpha-(1,2)-fucosyltransferase 2 Proteins 0.000 description 48
- 102100040837 Galactoside alpha-(1,2)-fucosyltransferase 2 Human genes 0.000 description 46
- 241000894006 Bacteria Species 0.000 description 35
- 238000000034 method Methods 0.000 description 33
- 102000004190 Enzymes Human genes 0.000 description 27
- 108090000790 Enzymes Proteins 0.000 description 27
- 241000588724 Escherichia coli Species 0.000 description 18
- 241000606125 Bacteroides Species 0.000 description 15
- 241000193403 Clostridium Species 0.000 description 15
- 150000001413 amino acids Chemical group 0.000 description 15
- 102000039446 nucleic acids Human genes 0.000 description 14
- 108020004707 nucleic acids Proteins 0.000 description 14
- 150000007523 nucleic acids Chemical class 0.000 description 14
- 229920001542 oligosaccharide Polymers 0.000 description 14
- 150000002482 oligosaccharides Chemical class 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 102000005936 beta-Galactosidase Human genes 0.000 description 10
- 108010005774 beta-Galactosidase Proteins 0.000 description 10
- 241000543747 Parabacteroides johnsonii Species 0.000 description 9
- 241001135223 Prevotella melaninogenica Species 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 241000605902 Butyrivibrio Species 0.000 description 8
- 241001538100 Methanosphaerula Species 0.000 description 8
- 241000611831 Prevotella sp. Species 0.000 description 8
- 241000607142 Salmonella Species 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000002864 sequence alignment Methods 0.000 description 7
- 241001148536 Bacteroides sp. Species 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 101150066555 lacZ gene Proteins 0.000 description 5
- SNFSYLYCDAVZGP-OLAZETNGSA-N 2'-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@H](O)[C@@H]1O SNFSYLYCDAVZGP-OLAZETNGSA-N 0.000 description 4
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical class C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 4
- LQEBEXMHBLQMDB-UHFFFAOYSA-N GDP-L-fucose Natural products OC1C(O)C(O)C(C)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C3=C(C(N=C(N)N3)=O)N=C2)O1 LQEBEXMHBLQMDB-UHFFFAOYSA-N 0.000 description 4
- LQEBEXMHBLQMDB-JGQUBWHWSA-N GDP-beta-L-fucose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C3=C(C(NC(N)=N3)=O)N=C2)O1 LQEBEXMHBLQMDB-JGQUBWHWSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 101150001899 lacY gene Proteins 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 101710149180 Alpha-(1,4)-fucosyltransferase Proteins 0.000 description 3
- 241000193417 Brevibacillus laterosporus Species 0.000 description 3
- 241000194033 Enterococcus Species 0.000 description 3
- 101000819503 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 Proteins 0.000 description 3
- 101001022183 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 Proteins 0.000 description 3
- 101001022175 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 Proteins 0.000 description 3
- 101000862213 Homo sapiens Alpha-(1,3)-fucosyltransferase 11 Proteins 0.000 description 3
- 101000819497 Homo sapiens Alpha-(1,3)-fucosyltransferase 7 Proteins 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 101150043276 Lon gene Proteins 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- RPKLZQLYODPWTM-KBMWBBLPSA-N cholanoic acid Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCC(O)=O)C)[C@@]1(C)CC2 RPKLZQLYODPWTM-KBMWBBLPSA-N 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 101150086432 lacA gene Proteins 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940062827 2'-fucosyllactose Drugs 0.000 description 2
- HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 description 2
- 101100325906 Bacillus subtilis (strain 168) ganA gene Proteins 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 241000218492 Lactobacillus crispatus Species 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 2
- 241000194036 Lactococcus Species 0.000 description 2
- BRHHWBDLMUBZQQ-JZEMXWCPSA-N Lactodifucotetraose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]([C@H](O)[C@H](O)CO)[C@H](C=O)O[C@@H]1[C@H](O[C@H]2[C@H]([C@H](O)[C@H](O)[C@H](C)O2)O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 BRHHWBDLMUBZQQ-JZEMXWCPSA-N 0.000 description 2
- LKOHREGGXUJGKC-UHFFFAOYSA-N Lactodifucotetraose Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)OC2CO)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1O LKOHREGGXUJGKC-UHFFFAOYSA-N 0.000 description 2
- 108010038016 Mannose-1-phosphate guanylyltransferase Proteins 0.000 description 2
- 108091022912 Mannose-6-Phosphate Isomerase Proteins 0.000 description 2
- 102000048193 Mannose-6-phosphate isomerases Human genes 0.000 description 2
- 241000588912 Pantoea agglomerans Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 101100111413 Thermoanaerobacter pseudethanolicus (strain ATCC 33223 / 39E) lacZ gene Proteins 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- RQNFGIWYOACERD-OCQMRBNYSA-N alpha-L-Fucp-(1->4)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)[C@@H]2NC(C)=O)O[C@H]2[C@H]([C@H](O)[C@H](O)[C@H](C)O2)O)O[C@H](CO)[C@H](O)[C@@H]1O RQNFGIWYOACERD-OCQMRBNYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- -1 fucosyl oligosaccharide Chemical class 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- RQNFGIWYOACERD-UHFFFAOYSA-N lacto-N-Difucosylhexaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(CO)OC(OC3C(C(OC4C(OC(O)C(O)C4O)CO)OC(CO)C3O)O)C2NC(C)=O)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1O RQNFGIWYOACERD-UHFFFAOYSA-N 0.000 description 2
- OQIUPKPUOLIHHS-UHFFFAOYSA-N lacto-N-difucohexaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(CO)OC(OC3C(C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C3O)O)C2NC(C)=O)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1O OQIUPKPUOLIHHS-UHFFFAOYSA-N 0.000 description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000002887 multiple sequence alignment Methods 0.000 description 2
- 101150072314 thyA gene Proteins 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 101150018163 wcaJ gene Proteins 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 241000702460 Akkermansia Species 0.000 description 1
- 101100075927 Aspergillus aculeatus mndA gene Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000193422 Bacillus lentus Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000194106 Bacillus mycoides Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 101100427060 Bacillus spizizenii (strain ATCC 23059 / NRRL B-14472 / W23) thyA1 gene Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000770536 Bacillus thermophilus Species 0.000 description 1
- 241000217846 Bacteroides caccae Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- 241000588919 Citrobacter freundii Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 101100022282 Escherichia coli O157:H7 manC2 gene Proteins 0.000 description 1
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
- 101100153154 Escherichia phage T5 thy gene Proteins 0.000 description 1
- 240000001973 Ficus microcarpa Species 0.000 description 1
- 108010062427 GDP-mannose 4,6-dehydratase Proteins 0.000 description 1
- 102000002312 GDPmannose 4,6-dehydratase Human genes 0.000 description 1
- 241001674329 Helicobacter pylori 26695 Species 0.000 description 1
- 101150098499 III gene Proteins 0.000 description 1
- 241001112693 Lachnospiraceae Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241001561398 Lactobacillus jensenii Species 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000520272 Pantoea Species 0.000 description 1
- 241000588701 Pectobacterium carotovorum Species 0.000 description 1
- 241000605861 Prevotella Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- 101100313751 Rickettsia conorii (strain ATCC VR-613 / Malish 7) thyX gene Proteins 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- 241000204117 Sporolactobacillus Species 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 101150057615 Syn gene Proteins 0.000 description 1
- 241001470488 Tannerella Species 0.000 description 1
- 241000520244 Tatumella citrea Species 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 241001246487 [Clostridium] bolteae Species 0.000 description 1
- 229960001456 adenosine triphosphate Drugs 0.000 description 1
- FZIVHOUANIQOMU-YIHIYSSUSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)O[C@H](CO)[C@H]2O)NC(C)=O)O[C@H](CO)[C@H](O)[C@@H]1O FZIVHOUANIQOMU-YIHIYSSUSA-N 0.000 description 1
- 238000007845 assembly PCR Methods 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 101150109249 lacI gene Proteins 0.000 description 1
- FZIVHOUANIQOMU-UHFFFAOYSA-N lacto-N-fucopentaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(OC3C(C(OC4C(OC(O)C(O)C4O)CO)OC(CO)C3O)O)OC(CO)C2O)NC(C)=O)OC(CO)C(O)C1O FZIVHOUANIQOMU-UHFFFAOYSA-N 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 108010060845 lactose permease Proteins 0.000 description 1
- 101150088678 manB gene Proteins 0.000 description 1
- 101150032120 manC gene Proteins 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 101150117960 rcsA gene Proteins 0.000 description 1
- 101150031509 rcsB gene Proteins 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461993742P | 2014-05-15 | 2014-05-15 | |
| US61/993,742 | 2014-05-15 | ||
| PCT/US2015/030823 WO2015175801A1 (en) | 2014-05-15 | 2015-05-14 | Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020086439A Division JP2020188761A (ja) | 2014-05-15 | 2020-05-18 | フコシル化オリゴ糖の生産に使用するためのアルファ（１，２）フコシルトランスフェラーゼ・シンジーン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017515455A JP2017515455A (ja) | 2017-06-15 |
| JP2017515455A5 true JP2017515455A5 (enExample) | 2017-12-21 |
Family
ID=54480689
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549476A Withdrawn JP2017515455A (ja) | 2014-05-15 | 2015-05-14 | フコシル化オリゴ糖の生産に使用するためのアルファ（１，２）フコシルトランスフェラーゼ・シンジーン |
| JP2020086439A Pending JP2020188761A (ja) | 2014-05-15 | 2020-05-18 | フコシル化オリゴ糖の生産に使用するためのアルファ（１，２）フコシルトランスフェラーゼ・シンジーン |
| JP2022156260A Pending JP2022173457A (ja) | 2014-05-15 | 2022-09-29 | フコシル化オリゴ糖の生産に使用するためのアルファ（１，２）フコシルトランスフェラーゼ・シンジーン |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020086439A Pending JP2020188761A (ja) | 2014-05-15 | 2020-05-18 | フコシル化オリゴ糖の生産に使用するためのアルファ（１，２）フコシルトランスフェラーゼ・シンジーン |
| JP2022156260A Pending JP2022173457A (ja) | 2014-05-15 | 2022-09-29 | フコシル化オリゴ糖の生産に使用するためのアルファ（１，２）フコシルトランスフェラーゼ・シンジーン |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11046984B2 (enExample) |
| EP (2) | EP3083938B1 (enExample) |
| JP (3) | JP2017515455A (enExample) |
| KR (2) | KR20230113650A (enExample) |
| CN (1) | CN106795484B (enExample) |
| AU (1) | AU2015259088B2 (enExample) |
| CA (1) | CA2945661C (enExample) |
| ES (1) | ES2962258T3 (enExample) |
| HU (1) | HUE064860T2 (enExample) |
| MX (1) | MX2016014807A (enExample) |
| SG (2) | SG11201609366TA (enExample) |
| WO (1) | WO2015175801A1 (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6129821B2 (ja) | 2011-05-13 | 2017-05-17 | グリコシン リミテッド ライアビリティー カンパニー | プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用 |
| US9029136B2 (en) * | 2012-07-25 | 2015-05-12 | Glycosyn LLC | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides |
| DE14769797T1 (de) | 2013-03-14 | 2016-06-23 | Glycosyn LLC | Mikroorganismen und Verfahren zur Herstellung sialylierter und N-acetylglucosamin-haltiger Oligosaccharide |
| SG11201609366TA (en) | 2014-05-15 | 2016-12-29 | Glycosyn LLC | Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides |
| EP3390652B1 (en) * | 2015-12-18 | 2024-12-04 | Glycom A/S | Fermentative production of oligosaccharides |
| WO2017106864A1 (en) * | 2015-12-18 | 2017-06-22 | The Regents Of The University Of California | Te2ft enzyme for enzymatic synthesis of alpha1-2-fucosides |
| CN106190937B9 (zh) * | 2016-07-18 | 2020-12-01 | 南开大学 | 一种构建重组大肠杆菌生物合成2’-岩藻乳糖的方法 |
| DK3375291T3 (da) * | 2017-03-17 | 2022-10-31 | Chr Hansen Hmo Gmbh | Fremgangsmåde til hæmning af isomerisering af et reducerende saccharid efter termisk behandling |
| EP3425052A1 (en) * | 2017-07-07 | 2019-01-09 | Jennewein Biotechnologie GmbH | Fucosyltransferases and their use in producing fucosylated oligosaccharides |
| EP3438122A1 (en) * | 2017-08-01 | 2019-02-06 | OligoScience Biotechnology GmbH | Microorganism for producing human milk oligosaccharide |
| KR101953375B1 (ko) * | 2017-11-20 | 2019-02-28 | 고려대학교 산학협력단 | 다양하고 신규한 퓨코실 올리고당의 제조법 및 이의 용도 |
| CN109402020B (zh) * | 2018-11-30 | 2020-08-04 | 江南大学 | 一株高产精氨酸氨肽酶的瑞士乳杆菌及其应用 |
| CN109735479B (zh) * | 2019-01-30 | 2022-04-01 | 光明乳业股份有限公司 | 一种合成2’-岩藻糖基乳糖的重组枯草芽孢杆菌及其构建方法与应用 |
| RS65200B1 (sr) * | 2019-03-04 | 2024-03-29 | Aurealis Therapeutics AG | Prokariotski ekspresioni sistem inducibilan hloridom |
| WO2020246585A1 (ja) | 2019-06-05 | 2020-12-10 | 森永乳業株式会社 | 栄養組成物 |
| JP2023506287A (ja) * | 2019-12-17 | 2023-02-15 | インバイオス エン．フェー． | ラクトースを変換するアルファ－１，２－フコシルトランスフェラーゼ酵素 |
| CN111218488B (zh) * | 2020-02-10 | 2022-11-15 | 中国科学院上海高等研究院 | 一种利用大肠杆菌生产2’-岩藻糖基乳糖的方法 |
| CN111471606B (zh) * | 2020-03-17 | 2022-03-08 | 山东大学 | 一株优化的高产岩藻糖基乳糖的酿酒酵母菌株及其应用 |
| CN111471605B (zh) * | 2020-03-17 | 2022-03-08 | 山东大学 | 一株高产岩藻糖基乳糖的酿酒酵母工程菌株及其应用 |
| KR102719035B1 (ko) * | 2020-04-20 | 2024-10-18 | 주식회사 리비옴 | 혈관 작동성 장 펩티드를 발현하는 미생물, 및 그의 용도 |
| EP3954769A1 (en) * | 2020-08-10 | 2022-02-16 | Inbiose N.V. | Production of oligosaccharide mixtures by a cell |
| US11331329B2 (en) | 2020-05-13 | 2022-05-17 | Glycosyn LLC | Fucosylated oligosaccharides for prevention of coronavirus infection |
| CA3178736A1 (en) | 2020-05-13 | 2021-11-18 | Ardythe L. Morrow | 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation |
| CN113969256A (zh) * | 2020-07-24 | 2022-01-25 | 上海交通大学 | 一种生产n-乙酰氨基葡萄糖的菌株及其构建方法和应用 |
| EP4192944A1 (en) | 2020-08-10 | 2023-06-14 | Inbiose N.V. | Production of oligosaccharide mixtures by a cell |
| EP4200318A4 (en) * | 2020-08-19 | 2024-06-12 | Conagen Inc. | BIOSYNTHETIC PRODUCTION OF 2-FUCOSYLLACTOSE |
| KR102793833B1 (ko) * | 2020-12-31 | 2025-04-11 | 주식회사 삼양사 | 푸코오스 전이효소를 발현하는 재조합 미생물 및 이를 이용한 2’-푸코실락토오스 제조방법 |
| KR102633804B1 (ko) * | 2020-12-31 | 2024-02-05 | 주식회사 삼양사 | 재조합 바실러스 속 미생물 및 이를 이용한 모유올리고당 제조방법 |
| WO2023182970A1 (en) * | 2021-02-19 | 2023-09-28 | The Regents Of The University Of California | Methods for production of fucosylated oligosaccharides in recombinant cell culture |
| WO2022176994A1 (ja) * | 2021-02-19 | 2022-08-25 | 協和発酵バイオ株式会社 | 改変されたα１，２－フコシルトランスフェラーゼ活性を有する蛋白質及びフコース含有糖質の製造法 |
| DK181242B1 (en) | 2021-05-17 | 2023-05-30 | Dsm Ip Assets Bv | GENETICALLY ENGINEERED CELLS COMPRISING A RECOMBINANT NUCLEIC ACID SEQUNCE ENCODING AN α-1,2-FUCOSYLTRANSFERASE CAPABLE OF PRODUCING LNFP-I, NUCLEIC ACID SEQUENCES ENCODING SAME AND METHODS FOR USE OF SAME |
| EP4370664A1 (en) * | 2021-07-16 | 2024-05-22 | Inbiose N.V. | Lacto-n-biose converting fucosyltransferases |
| CN113817701B (zh) * | 2021-09-30 | 2023-08-18 | 中南大学 | α-1,2-岩藻糖基转移酶突变体及其应用 |
| CN113832092B (zh) * | 2021-10-20 | 2023-10-03 | 江南大学 | 一种提高乳酰-n-岩藻五糖产量的基因工程菌及其生产方法 |
| CN116286919A (zh) * | 2021-12-03 | 2023-06-23 | 虹摹生物科技(上海)有限公司 | 基因工程菌及利用其制备岩藻糖基化寡糖的方法 |
| KR20240017427A (ko) * | 2022-07-29 | 2024-02-08 | 주식회사 진켐 | 3-푸코실락토스 생산용 유전자 조작 미생물 및 이를 이용한 방법 |
| CN116042671B (zh) * | 2023-02-14 | 2024-11-22 | 华熙生物科技股份有限公司 | 一种用于制备母乳寡糖的核酸分子、表达载体和微生物 |
| CN116769808B (zh) * | 2023-02-27 | 2025-06-10 | 江南大学 | 一种专一生产2′-岩藻糖基乳糖的菌株及应用 |
| WO2025087087A1 (zh) * | 2023-10-23 | 2025-05-01 | 山东恒鲁生物科技有限公司 | 一种岩藻糖基转移酶多肽及其应用 |
| CN119614406B (zh) * | 2023-10-23 | 2025-09-19 | 恒睿（青岛）生物科技有限公司 | 一种克鲁维酵母基因修饰细胞 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2796082B1 (fr) * | 1999-07-07 | 2003-06-27 | Centre Nat Rech Scient | Procede de production d'oligosaccharides |
| JP2012503491A (ja) * | 2008-09-25 | 2012-02-09 | グリコシン インコーポレイテッド | プロバイオティック酵母を操作するための組成物および方法 |
| ES2439507T3 (es) * | 2011-01-20 | 2014-01-23 | Jennewein Biotechnologie Gmbh | Fucosiltransferasas novedosas y sus aplicaciones |
| DE12746649T1 (de) * | 2011-02-16 | 2016-09-29 | Glycosyn LLC | Biosynthese menschlicher milcholigosaccaride in manipulierten Bakterien |
| US9029136B2 (en) * | 2012-07-25 | 2015-05-12 | Glycosyn LLC | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides |
| ES2715010T3 (es) * | 2014-03-31 | 2019-05-31 | Jennewein Biotechnologie Gmbh | Fermentación total de oligosacáridos |
| SG11201609366TA (en) | 2014-05-15 | 2016-12-29 | Glycosyn LLC | Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides |
-
2015
- 2015-05-14 SG SG11201609366TA patent/SG11201609366TA/en unknown
- 2015-05-14 KR KR1020237024435A patent/KR20230113650A/ko not_active Ceased
- 2015-05-14 EP EP15792578.5A patent/EP3083938B1/en active Active
- 2015-05-14 HU HUE15792578A patent/HUE064860T2/hu unknown
- 2015-05-14 CN CN201580028020.2A patent/CN106795484B/zh active Active
- 2015-05-14 SG SG10202010599TA patent/SG10202010599TA/en unknown
- 2015-05-14 CA CA2945661A patent/CA2945661C/en active Active
- 2015-05-14 EP EP23203630.1A patent/EP4293033A3/en not_active Withdrawn
- 2015-05-14 ES ES15792578T patent/ES2962258T3/es active Active
- 2015-05-14 AU AU2015259088A patent/AU2015259088B2/en not_active Ceased
- 2015-05-14 JP JP2016549476A patent/JP2017515455A/ja not_active Withdrawn
- 2015-05-14 WO PCT/US2015/030823 patent/WO2015175801A1/en not_active Ceased
- 2015-05-14 US US15/307,914 patent/US11046984B2/en not_active Expired - Fee Related
- 2015-05-14 KR KR1020167033842A patent/KR20170035835A/ko not_active Ceased
- 2015-05-14 MX MX2016014807A patent/MX2016014807A/es unknown
-
2020
- 2020-05-18 JP JP2020086439A patent/JP2020188761A/ja active Pending
-
2021
- 2021-06-22 US US17/354,819 patent/US11643675B2/en active Active
-
2022
- 2022-09-29 JP JP2022156260A patent/JP2022173457A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017515455A5 (enExample) | ||
| CN114981290B (zh) | Hmo生产 | |
| JP7591501B2 (ja) | フコシル化オリゴ糖の合成 | |
| US12428657B2 (en) | HMO production | |
| US12351806B2 (en) | HMO production | |
| KR102630559B1 (ko) | 인간 모유 올리고당을 생산하기 위한 미생물 | |
| CN114981291B (zh) | Hmo产生 | |
| DK181242B1 (en) | GENETICALLY ENGINEERED CELLS COMPRISING A RECOMBINANT NUCLEIC ACID SEQUNCE ENCODING AN α-1,2-FUCOSYLTRANSFERASE CAPABLE OF PRODUCING LNFP-I, NUCLEIC ACID SEQUENCES ENCODING SAME AND METHODS FOR USE OF SAME | |
| DK180952B1 (en) | A dfl-producing strain | |
| CN101636491A (zh) | 由gras表达的食品级嗜热性阿拉伯糖异构酶以及使用其制备塔格糖的方法 | |
| US20240327886A1 (en) | Methods of producing hmo blend profiles with lnfp-i and lnt as the predominant compounds | |
| US20230109937A1 (en) | New major facilitator superfamily (mfs) protein (fred) in hmo production | |
| EA046005B1 (ru) | НОВЫЙ БЕЛОК СУПЕРСЕМЕЙСТВА ОСНОВНЫХ ПЕРЕНОСЧИКОВ (MFS) (Fred) В ПРОИЗВОДСТВЕ ОГМ | |
| EA046241B1 (ru) | Получение огм | |
| EA046260B1 (ru) | Получение огм | |
| CN116802302A (zh) | 唾液酸化hmo生产中的新主要易化子超家族（mfs）蛋白（fred） | |
| EA046248B1 (ru) | Получение огм |